brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastische mittel - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
ipravent 20 mikrogramm/sprühstoß druckgasinhalation, lösung
cipla europe nv (8154263) - ipratropiumbromid 1 h<2>o - druckgasinhalation, lösung - teil 1 - druckgasinhalation, lösung; ipratropiumbromid 1 h<2>o (19720) 20,87 mikrogramm
actonel 75 mg filmtablette
theramex ireland - risedronat-natrium - filmtablette - 75 mg - risedronat-natrium 75 mg - risedronic acid